EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access

Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP ‐ INDIA Study

Nipun Verma iD, Rohit Mehtani iD, Arun Valsan, Pratibha Garg, Rohit Kumar Nadda, Shilpa Prasad, Anand Sharma iD, Rohit Gupta iD, Balram Ji Omar, Naga Srikanth Darla, Roshan Agarwala iD, Mrinal Deb Barma and 23 more

Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (4) · 479-498

DOI: 10.1111/apt.70716 ↗

At a glance

Multizentrische Studie in Alimentary Pharmacology & Therapeutics, published online on 2026-05-13. Written by Nipun Verma and 34 co-authors. Institution: Department of Hepatology, PGIMER, Chandigarh, India. Major MEDLINE topics: Anti-Bacterial Agents, Bacterial Infections, Drug Resistance, Multiple, Bacterial, Liver Cirrhosis. Cited 2 times so far (Crossref); 24 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims The rising burden of multidrug‐resistant (MDRO) and carbapenem‐resistant organisms (CRO) among patients with cirrhosis and spontaneous bacterial peritonitis (SBP) is compromising the effectiveness of standard empiric therapy. This multicentre study evaluated resistance patterns, independent predictors of MDRO and CRO infection, and clinical outcomes to inform risk‐based empiric therapy and antimicrobial stewardship in ascitic infections.

Methods

We analysed clinical characteristics and outcomes of hospitalized patients with cirrhosis and culture‐positive ascitic fluid infections from 13 centres across India. SBP was defined as ascitic neutrophil count (ANC) ≥ 250/mm 3 ; culture‐positive cases with ANC < 250/mm 3 were classified as non‐neutrocytic bacterascites (NNBA). Predictors of MDRO, CRO and mortality were assessed through regression models.

Results

Among 319 patients (median age 49 years; 79.9% male; 65.8% with acute‐on‐chronic liver failure), 74.6% of isolates were gram‐negative. MDRO and CRO were identified in 53.6% and 24.1% of infections, respectively. Nosocomial/healthcare‐associated acquisition, circulatory failure, elevated leukocyte count and SBP prophylaxis were independently associated with MDRO infection, while the nosocomial setting, leukocyte count and circulatory failure predicted CRO infection. MDRO infection was associated with poorer survival. Respiratory failure, liver failure, systemic inflammation, presence of MDRO and higher ACLF severity independently predicted mortality. Nearly one‐third of culture‐positive infections had ANC < 250/mm 3 yet showed similar mortality to SBP. Based on clinical setting and risk profile, an empiric treatment framework was proposed.

Conclusions

There is a high burden of MDRO and CRO in ascitic infections among hospitalized patients with cirrhosis, with clinically relevant impact on outcomes. Empiric antibiotic selection should be guided by acquisition setting, illness severity and resistance risk factors, with stewardship oversight. Similar outcomes between NNBA and SBP suggest that microbiological evidence, rather than neutrophil count alone, should guide decisions.

Subjects

MeSH terms (MEDLINE)

Anti-Bacterial AgentsBacterial InfectionsDrug Resistance, Multiple, BacterialLiver CirrhosisPeritonitisAdultAgedFemaleHumansMaleMiddle AgedCarbapenemsIndiaRisk Factors

Author keywords

antimicrobial resistancecarbapenem‐resistant organismscirrhosisempiric antibiotic therapymultidrug‐resistant organismsspontaneous bacterial peritonitis

Substances

Anti-Bacterial AgentsCarbapenems

Authors and institutions

  • Department of Hepatology, PGIMER, Chandigarh, India.
  • Department of Hepatology, Amrita School of Medicine, Amrita Vishvavidyapeetham, Faridabad, Haryana, India.
  • Department of Hepatology, Amrita Institute of Medical Sciences, Kochi, India.
  • Department of Gastroenterology, AIIMS, Rishikesh, India.
  • Department of Microbiology, AIIMS, Rishikesh, India.
  • Department of Gastroenterology, Apollo Hospitals, Guwahati, India.

ORCID profiles: Nipun Verma, Rohit Mehtani, Anand Sharma, Rohit Gupta, Roshan Agarwala, Surender Singh, Arka De, Madhumita Premkumar

Cite

APA

Verma, N., Mehtani, R., Valsan, A., Garg, P., Nadda, R. K., Prasad, S., Sharma, A., Gupta, R., Omar, B. J., Darla, N. S., Agarwala, R., Barma, M. D., Sarma, M., Mandot, A., Khot, W., Shalimar, Shukla, A., Vaidya, A., Prasad, M., …, & Duseja, A. (2026). Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP ‐ INDIA Study. Alimentary Pharmacology & Therapeutics, 64(4), 479-498. https://doi.org/10.1111/apt.70716

Vancouver

Verma N, Mehtani R, Valsan A, Garg P, Nadda RK, Prasad S, et al. Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP ‐ INDIA Study. Alimentary Pharmacology & Therapeutics. 2026;64(4):479-498. doi:10.1111/apt.70716

BibTeX
@article{Verma2026,
  author = {Verma, Nipun and Mehtani, Rohit and Valsan, Arun and Garg, Pratibha and Nadda, Rohit Kumar and Prasad, Shilpa and Sharma, Anand and Gupta, Rohit and Omar, Balram Ji and Darla, Naga Srikanth and Agarwala, Roshan and Barma, Mrinal Deb and Sarma, Mandira and Mandot, Ameet and Khot, Wasim and Shalimar and Shukla, Akash and Vaidya, Arun and Prasad, Mithra and Praharaj, Dibyalochan and Anand, Anil C and Dhiman, Radha Krishan and Singh, Surender and Choudhary, Narendra Singh and Kulkarni, Anand and Satsangi, Sandeep and Rathi, Sahaj and De, Arka and Premkumar, Madhumita and Taneja, Sunil and Singh, Virendra and Angrup, Archana and Taneja, Neelam and Shafiq, Nusrat and Duseja, Ajay},
  title = {Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP ‐ INDIA Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {4},
  pages = {479--498},
  doi = {10.1111/apt.70716}
}
Start for free →